Araçlar ile Ekonomik etkinlikler ile ilgili alarm oluşturmak
ve takip ettiğiniz yazarların yayınları için kayıt olun.
Ücretsiz Kayıt Olun Hesabınız var mı? Giriş Yapın
49,57
-0,12
-0,24%
Kurlar
Tüm Araç Çeşitleri
- Tüm Araç Çeşitleri
- Endeksler
- Hisse Senetleri
- ETF'ler
- Fonlar
- Emtia
- Dövizler
- Kripto Para
- Tahviller
- Sertifikalar
Lütfen başka bir arama deneyiniz
Premium Verilerde 50% İndirim InvestingPro İNDİRİMİ KULLAN
Pgim Jennison Health Sciences Fund- Class Z (PHSZX)
Portföy'e Ekle/Kaldır
Portföye Ekle
Prudential Jennison Health Sciences Z
49,57
-0,12
-0,24%
- Genel Bakış
- Profil
- Geçmiş Veriler
- Varlıklar
PHSZX Genel Bakış
Bu sayfada Pgim Jennison Health Sciences Fund- Class Z hakkında detaylı bir profile ulaşabilirsiniz. Yönetim, toplam varlıklar, yatırım stratejisi, iletişim bilgileri ve PHSZX için diğer bilgileri görüntüleyin.
İrtibat Bilgisi
Adres
One Seaport Plaza
New York,NY 10292
United States
New York,NY 10292
United States
Telefon
+1 8002251852
Üst Düzey Yöneticiler
| İsim | Başlık | B.Tarihi | Bitiş |
|---|---|---|---|
| Daniel Matviyenko | Managing Director | 2020 | Şimdi |
| Biyografi | Dan Matviyenko is a portfolio manager for Jennison’s healthcare strategies. He is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2020, Dan was with Malleus Capital as founder, chief investment officer, and portfolio manager. Prior to that, he held various senior positions at Tudor Investment as partner and portfolio manager as well as at UBS O’Connor as an executive director and portfolio manager. Dan received a BS in finance from the University of Connecticut. | ||
| Debra Netschert | Managing Director | 2015 | Şimdi |
| Biyografi | Debra Netschert is a portfolio manager for Jennison’s healthcare strategies. She is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2008, she was with Magnetar Capital as a senior analyst specializing in health care. Prior to that, she worked at Amaranth Advisors focusing on biopharmaceuticals and at Lazard Capital Markets covering biotechnology. Debra began her research career as an associate biotechnology analyst at UBS. She received a BS in health science and MS in physical therapy from Boston University. | ||
| David Chan | Portfolio Manager | 1999 | 2022 |
| Biyografi | David Chan, CFA, is a Managing Director and a Health Sciences Equity Portfolio Manager and Research Analyst of Jennison. Mr. Chan joined Jennison Associates in May 1992. He was previously with the Boston Consulting Group, where he was a team leader and consultant on projects in a wide variety of industries, but with a special focus in the health care area. Mr. Chan has also worked in various positions in the film and television industry. He received a BA in biochemistry from Harvard University and an MBA from Columbia University. | ||
| Michael A. Del Balso | Director | 2000 | 2017 |
| Biyografi | Michael Del Balso is a large cap growth portfolio manager. He joined Jennison in 1972 as a research analyst. He later served as the director of research and became a portfolio manager in 1999. Prior to Jennison, he was a portfolio manager and research analyst at White, Weld & Company. Michael received a BS in industrial administration from Yale University and an MBA from Columbia University Business School. | ||
| John Van Belle | Managing Director | 1999 | 2002 |
| Biyografi | John Van Belle, PhD, is a Managing Director and Portfolio Manager for QMA working within the Quantitative Equity team. In this capacity, he manages global and non-US portfolios. Prior to joining QMA, John taught Economics and Finance at the University of Virginia and Rutgers Graduate School of Management and was a Vice President in Currency Management Consulting at both Bankers Trust and Citibank. Previously, he worked in the Research department of the Federal Reserve Bank of New York. He has published numerous articles in the fields of Economics and Finance. John earned a BS in Economics from St. Joseph's College and a PhD in Economics from the University of Virginia. | ||
| Kathleen A. McCarragher | Managing Director | 1999 | 2000 |
| Biyografi | Kathleen McCarragher is the head of growth equity and a large cap growth equity portfolio manager. She is responsible for overseeing the investment process, strategy implementation, and risk management for Jennison's growth equity platform. Kathleen is also a member of the Jennison Management Team, ESG Investment Leadership Team, and Jennison Board of Directors. Before joining Jennison in 1998, she was a managing director and the director of large cap growth equities with Weiss, Peck & Greer. Prior to that, she was an investor with State Street Research & Management. Kathleen received a BBA, summa cum laude, in finance and economics from the University of Wisconsin-Eau Claire and an MBA from Harvard Business School. | ||
Pgim Jennison Health Sciences Fund- Class Z hakkında düşüncelerinizi yazın
Bu grafiği silmek istediğinize emin misiniz?
Sil İptal
Ekteki grafiği yeni bir grafikle değiştirmek istiyor musunuz?
Değiştir İptal
Yorum Kuralları
Yoruma Grafik Ekle
Engellemeyi Onayla
%USER_NAME% isimli kullanıcıyı engellemek istediğinize emin misiniz?
Bunu onayladıktan sonra %USER_NAME% isimli kullanıcı ile birbirinizin yorumlarını görmeyeceksiniz.
%USER_NAME% başarıyla Engelli Listesine eklendi
Bu kişinin engelini yeni kaldırdınız. Yeniden engellemek için 48 saat beklemeniz gerekmektedir.
Yorumu şikayet et
Yorum silinmeli, çünkü:
Yorum Şikayet Edildi
Teşekkürler!
Şikayetiniz yönetim ekibimize iletildi